DK0490380T3 - Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel - Google Patents

Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel

Info

Publication number
DK0490380T3
DK0490380T3 DK91121354T DK91121354T DK0490380T3 DK 0490380 T3 DK0490380 T3 DK 0490380T3 DK 91121354 T DK91121354 T DK 91121354T DK 91121354 T DK91121354 T DK 91121354T DK 0490380 T3 DK0490380 T3 DK 0490380T3
Authority
DK
Denmark
Prior art keywords
antineoplastic
heptanediamine
ethylamino
propyl
bis
Prior art date
Application number
DK91121354T
Other languages
English (en)
Inventor
Nellikunja J Prakash
Terry L Bowlin
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0490380T3 publication Critical patent/DK0490380T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91121354T 1990-12-13 1991-12-12 Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel DK0490380T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62681490A 1990-12-13 1990-12-13

Publications (1)

Publication Number Publication Date
DK0490380T3 true DK0490380T3 (da) 1998-09-23

Family

ID=24511975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91121354T DK0490380T3 (da) 1990-12-13 1991-12-12 Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel

Country Status (11)

Country Link
EP (1) EP0490380B1 (da)
JP (1) JPH04275233A (da)
KR (1) KR100195423B1 (da)
AT (1) ATE163264T1 (da)
AU (1) AU648846B2 (da)
DE (1) DE69128926T2 (da)
DK (1) DK0490380T3 (da)
ES (1) ES2113870T3 (da)
GR (1) GR3026432T3 (da)
IE (1) IE914331A1 (da)
ZA (1) ZA919695B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69728220T2 (de) * 1996-01-31 2005-01-27 Japan Science And Technology Corp., Kawaguchi Antitumormittel mit silizium und stickstoff enthaltenden verbindungen als hauptbestandteil
US6274561B1 (en) 1997-01-29 2001-08-14 Japan Science & Technology Corp. Antitumor agents comprising as the principal compounds containing silicon and nitrogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223340A (en) * 1987-02-03 1991-03-26 Merrell Dow Pharma Polyamine derivatives and pharmaceutical compositions
DE69018099T2 (de) * 1989-01-10 1995-08-03 Merrell Dow Pharma Polyamin-Derivate als antineoplastische Mittel.
AU628174B2 (en) * 1989-05-23 1992-09-10 Merrell Dow Pharmaceuticals Inc. A method of potentiating cell-mediated immunity utilizing polyamine derivatives

Also Published As

Publication number Publication date
ATE163264T1 (de) 1998-03-15
ES2113870T3 (es) 1998-05-16
EP0490380B1 (en) 1998-02-18
ZA919695B (en) 1992-09-30
DE69128926D1 (de) 1998-03-26
EP0490380A2 (en) 1992-06-17
IE914331A1 (en) 1992-06-17
KR920011481A (ko) 1992-07-24
DE69128926T2 (de) 1998-06-04
JPH04275233A (ja) 1992-09-30
AU8890791A (en) 1992-06-18
KR100195423B1 (ko) 1999-06-15
AU648846B2 (en) 1994-05-05
EP0490380A3 (en) 1993-03-10
GR3026432T3 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
HU0301601D0 (en) Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof
FI950947A0 (fi) Oraalisesti annettavat farmaseuttiset formulaatiot
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
ATE114974T1 (de) Abgabe von cytotoxischen mitteln.
DK0784613T3 (da) Colchicinderivater og den terapeutiske anvendelse deraf
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DK0490380T3 (da) Anvendelse af N,N'-bis[3-(ethylamino)propyl]-1,7-heptandiamin og et cytotoksisk middel
NZ229422A (en) Certain (2',5')-oligoadehylate derivatives and pharmaceutical use
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
ITMI911845A1 (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DK0678025T3 (da) Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform
EP0311467A3 (en) Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes
FR2715658B1 (fr) Dérivés de N-(3-aminopropyl)-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide, leur préparation et leur application en thérapeutique.
ATE8399T1 (de) 1,2,4-triazolo(4,3-a)chinolin-1-(2h)-one und diese verbindungen zur pharmazeutischen verwendung.
IT1257000B (it) Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.